1. Home
  2. TRVI vs CHMG Comparison

TRVI vs CHMG Comparison

Compare TRVI & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • CHMG
  • Stock Information
  • Founded
  • TRVI 2011
  • CHMG 1833
  • Country
  • TRVI United States
  • CHMG United States
  • Employees
  • TRVI N/A
  • CHMG N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • CHMG Major Banks
  • Sector
  • TRVI Health Care
  • CHMG Finance
  • Exchange
  • TRVI Nasdaq
  • CHMG Nasdaq
  • Market Cap
  • TRVI 211.4M
  • CHMG 222.5M
  • IPO Year
  • TRVI 2019
  • CHMG N/A
  • Fundamental
  • Price
  • TRVI $2.75
  • CHMG $51.56
  • Analyst Decision
  • TRVI Strong Buy
  • CHMG Hold
  • Analyst Count
  • TRVI 8
  • CHMG 1
  • Target Price
  • TRVI $9.13
  • CHMG $49.00
  • AVG Volume (30 Days)
  • TRVI 659.5K
  • CHMG 13.8K
  • Earning Date
  • TRVI 11-06-2024
  • CHMG 10-22-2024
  • Dividend Yield
  • TRVI N/A
  • CHMG 2.40%
  • EPS Growth
  • TRVI N/A
  • CHMG N/A
  • EPS
  • TRVI N/A
  • CHMG 4.53
  • Revenue
  • TRVI N/A
  • CHMG $93,478,000.00
  • Revenue This Year
  • TRVI N/A
  • CHMG N/A
  • Revenue Next Year
  • TRVI N/A
  • CHMG $9.64
  • P/E Ratio
  • TRVI N/A
  • CHMG $11.39
  • Revenue Growth
  • TRVI N/A
  • CHMG N/A
  • 52 Week Low
  • TRVI $0.97
  • CHMG $39.00
  • 52 Week High
  • TRVI $4.00
  • CHMG $52.59
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 37.52
  • CHMG 68.56
  • Support Level
  • TRVI $2.80
  • CHMG $51.45
  • Resistance Level
  • TRVI $3.22
  • CHMG $52.59
  • Average True Range (ATR)
  • TRVI 0.20
  • CHMG 0.82
  • MACD
  • TRVI -0.03
  • CHMG 0.35
  • Stochastic Oscillator
  • TRVI 14.68
  • CHMG 82.62

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. It provides financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, securities, and insurance brokerage services. Its business operations are organized into two lines of business: Banking, and Wealth Management services. It derives its revenues from the core banking business.

Share on Social Networks: